Macquarie Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Buy
60,807
+18,876
+45% +$1.24M 0.02% 448
2026
Q1
$2.98M Sell
41,931
-48,750
-54% -$3.84M 0.02% 457
2025
Q4
$7.44M Buy
90,681
+12,974
+17% +$1.01M 0.03% 337
2025
Q3
$5.84M Sell
77,707
-4,487
-5% -$335K 0.01% 925
2025
Q2
$6.09M Sell
82,194
-1,537,296
-95% -$107M 0.01% 939
2025
Q1
$131M Sell
1,619,490
-33,676
-2% -$2.89M 0.16% 166
2024
Q4
$128M Sell
1,653,166
-194,869
-11% -$16.6M 0.16% 178
2024
Q3
$173M Sell
1,848,035
-148,061
-7% -$12.4M 0.19% 131
2024
Q2
$156M Buy
1,996,096
+150,158
+8% +$12.2M 0.18% 144
2024
Q1
$168M Buy
1,845,938
+461,430
+33% +$38.4M 0.19% 132
2023
Q4
$107M Buy
1,384,508
+691,876
+100% +$48.5M 0.12% 233
2023
Q3
$47.1M Buy
692,632
+678,148
+4,682% +$49.3M 0.06% 423
2023
Q2
$1.18M Sell
14,484
-887
-6% -$70.8K ﹤0.01% 1329
2023
Q1
$1.26M Buy
+15,371
New +$1.1M ﹤0.01% 1307

Other funds holding GEHC

Macquarie Group's GEHC Position: Q2 2026 in Review

Macquarie Group increased its GE HealthCare (GEHC) stake by 45% in Q2 2026, buying an estimated $1.24M and bringing the position to 60,807 shares worth $3.89M. The position accounts for 0.02% of the portfolio, ranked #448.

Macquarie Group first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $173M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Macquarie Group held 60,807 shares of GE HealthCare worth $3.89M as of Q2 2026.
  • Macquarie Group bought 18,876 GE HealthCare shares in Q2 2026, an estimated $1.24M.
  • GE HealthCare made up 0.02% of Macquarie Group's portfolio in Q2 2026, its #448 holding.
  • Macquarie Group first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Macquarie Group's GE HealthCare position peaked at $173M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.